Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.13 USD | +0.30% | +0.40% | +0.70% |
Chart calendar Vir Biotechnology, Inc.
Upcoming events on Vir Biotechnology, Inc.
Past events on Vir Biotechnology, Inc.
2024-03-13 07:30 am | Barclays Global Healthcare Conference |
2024-03-10 | Leerink Partners Global Biopharma Conference |
2024-03-04 02:50 pm | TD Cowen Health Care Conference |
2024-02-22 04:30 pm | Q4 2023 Earnings Call |
2024-02-22 04:05 pm | Q4 2023 Earnings Release |
2024-01-10 06:45 pm | JPMorgan Healthcare Conference |
2023-11-13 04:45 pm | American Association for the Study of Liver Diseases Conference |
2023-11-13 03:00 pm | American Association for the Study of Liver Diseases Conference - Abstract No 5004 |
2023-11-13 01:00 pm | American Association for the Study of Liver Diseases Conference - Abstract No 48500 |
2023-11-10 12:00 pm | American Association for the Study of Liver Diseases Conference - Poster No: 1326-C |
2023-11-10 12:00 pm | American Association for the Study of Liver Diseases Conference - Poster No: 1457-C |
2023-11-10 12:00 pm | American Association for the Study of Liver Diseases Conference - Poster No: 1511-C |
2023-11-10 12:00 pm | American Association for the Study of Liver Diseases Conference - Poster No: 1480-C |
2023-11-10 12:00 pm | American Association for the Study of Liver Diseases Conference - Poster No: 1379-C |
2023-11-10 12:00 pm | American Association for the Study of Liver Diseases Conference - Poster No: 1257-C |
2023-11-02 04:30 pm | Q3 2023 Earnings Call |
2023-11-02 04:05 pm | Q3 2023 Earnings Release |
2023-10-25 10:00 am | H.C. Wainwright NASH Investor Conference |
2023-09-12 | H.C. Wainwright Global Investment Conference |
2023-09-12 08:10 am | Morgan Stanley Global Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 8,09 9,15 -11.6% | 76,4 79,3 -3.73% | 1 095 906 20.96% | 1 616 1 674 -3.48% | 86,2 79,7 8.1% | 41,4 |
EBITDA Million USD | Released Forecast Spread | -173 -191 9.36% | -292 -274 -6.42% | 427 664 -35.78% | 840 1 035 -18.89% | -665 -662 -0.36% | -562 |
EBIT Million USD | Released Forecast Spread | -178 -196 9.1% | -297 -280 -6.21% | 421 275 52.72% | 833 903 -7.69% | -684 -697 1.87% | -601 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -175 -193 9.35% | -299 -285 -4.72% | 550 463 18.77% | 754 777 -2.94% | -628 -660 4.8% | -548 |
Net income Million USD | Released Forecast Spread | -175 -193 9.26% | -299 -284 -5.1% | 529 365 44.82% | 516 597 -13.57% | -615 -626 1.76% | -571 |
EPS USD | Released Forecast Spread | -5,76 -2,77 -107.76% | -2,51 -2,38 -5.29% | 3,96 2,74 44.45% | 3,83 4,37 -12.32% | -4,59 -4,66 1.5% | -4,20 |
Announcement Date | 26/03/20 | 25/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 813 623 30.48% | 1 232 811 51.96% | -40,6 211 -119.24% | 375 114 227.76% | 49,4 134 -63.19% | 63,0 50,1 25.67% | 3,80 22,4 -83.04% | 2,64 8,77 -69.92% | 16,8 11,2 50.21% | 12,0 | 9,35 | 9,63 | 12,8 | 40,1 |
EBITDA Million USD | Released Forecast Spread | 573 958 -40.15% | 1 015 369 175.39% | -224 12,3 -1920.26% | 197 237 -16.98% | -149 142 -204.39% | -138 -146 5.51% | -214 | -182 -186 2.11% | -135 -148 8.97% | -123 | -141 | -144 | -131 | |
EBIT Million USD | Released Forecast Spread | 572 419 36.52% | 1 014 546 85.75% | -225 69,1 -426.15% | 195 -52,7 469.78% | -151 -50,0 -200.76% | -143 -124 -15.66% | -215 -177 -21.66% | -187 -185 -1.12% | -139 -166 16.1% | -155 | -153 | -159 | -151 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 546 450 21.32% | 922 588 56.72% | -234 109 -314.43% | 218 -37,4 682.25% | -152 -48,9 -210.26% | -143 -144 0.55% | -198 -178 -11.18% | -167 -177 5.97% | -121 -152 20.65% | -141 | -138 | -140 | -136 | |
Net income Million USD | Released Forecast Spread | 525 353 48.94% | 519 475 9.26% | -76,5 76,4 -200.09% | 175 -8,88 2074.08% | -102 -46,0 -120.72% | -141 -115 -22.36% | -195 -168 -16.13% | -163 -167 2.37% | -116 -136 14.5% | -144 | -144 | -147 | -143 | |
EPS USD | Released Forecast Spread | 3,92 2,63 49.22% | 3,85 3,54 8.76% | -0,58 0,26 -324.37% | 1,30 -0,07 2071.19% | -0,76 -0,34 -121.45% | -1,06 -0,86 -23.22% | -1,45 -1,25 -16.34% | -1,22 -1,25 2.03% | -0,86 -1,01 14.5% | -1,07 | -1,06 | -1,08 | -1,04 | |
Announcement Date | 24/02/22 | 05/05/22 | 09/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 22/02/24 | - | - | - | - | - |
Past sector events for Vir Biotechnology, Inc.
2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
2024-03-27 | SAB BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
2024-03-27 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
2024-03-27 | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
2024-03-26 | PHARMARON BEIJING CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-26 04:01 pm | KORRO BIO, INC.: Q4 2023 Earnings Release |
2024-03-26 06:00 am | GYRE THERAPEUTICS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Vir Biotechnology, Inc. - Nasdaq
- Calendar Vir Biotechnology, Inc.